MTOR and hepatocellular carcinoma: For instance, the knockdown of RIG-I in human HCC cell lines induces increased stemness of HCC cells.494 In AML, RIG-I restrains leukemic stemness by inhibiting Srt-induced AKT-mTOR activation, even without foreign RNA priming.493